PPMA presented the pharmaceutical industry’s perspective on key sector issues, including the deregulation of non-essential medicines. The meeting was presided
DRAP has officially issued draft amendments regarding the Drugs Labelling and Packing Rules and is requesting feedback from stakeholders. We
The Pak-China Business Conference concluded with $1.4 Billion in total investment commitments, including 42 final-day deals! 🚀 This historic partnership
The Pakistan Pharmaceutical Manufacturers Association (PPMA) successfully convened its 5th CEC Meeting, chaired by Dr. Mohammad Tahir Azam. Industry leaders
Tomorrow in Islamabad, the Pakistan–China B2B Investment Conference kicks off, bringing together over 450+ firms to forge the Sino-Pak Pharma
A new era of healthcare transparency begins. The Drug Regulatory Authority of Pakistan (DRAP) has established critical regulatory timelines to
Pakistan Pharmaceutical Manufacturer Association (PPMA) was established on January 26, 1961, and registered as the sole representative of the pharmaceutical industry on July 18, 1961.
